Effectiveness of monitoring free carnitine levels for L-carnitine supplementation in hemodialysis patients to maintain carnitine sufficiency and nutritional factors
- Resource Type
- Authors
- Etsuko Kumagai; Kazuhiro Furumachi; Shinji Takai; Keiko Hosohata
- Source
- Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis TherapyREFERENCES. 25(5)
- Subject
- Male
medicine.medical_specialty
medicine.medical_treatment
030232 urology & nephrology
030204 cardiovascular system & hematology
Gastroenterology
03 medical and health sciences
0302 clinical medicine
Muscular Diseases
Renal Dialysis
Internal medicine
Carnitine
Medicine
Humans
Hyperammonemia
Normal range
Aged
Free carnitine
business.industry
Hematology
Nephrology
Dietary Supplements
Kidney Failure, Chronic
Female
Hemodialysis
business
Cardiomyopathies
medicine.drug
- Language
- ISSN
- 1744-9987
We investigated the effectiveness of monitoring serum carnitine levels in hemodialysis patients receiving L-carnitine supplementation. One-hundred forty-five hemodialysis patients were divided into three groups. Group 1 consisted of patients (n = 30) who had been receiving supplementation before this study and then discontinued at the beginning. The remaining patients were divided into Group 2 (n = 13) and Group 3 (n = 102) based on their baseline free carnitine (FC) level